SAN DIEGO, July 08, 2020 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development and commercialization of ...
Please provide your email address to receive an email when new articles are posted on . ATLANTA — In this video exclusive, Maria Fleseriu, MD, FACE, reviews the pituitary research presented at the ...
Please provide your email address to receive an email when new articles are posted on . Data on several approved and investigational drugs were presented at the conference, including osilodrostat ...
People with the rare growth hormone disorder acromegaly have a significantly higher risk of developing various types of cancer, often at ages younger than typically seen in the general population, ...
People with the rare growth hormone disorder acromegaly have a significantly higher risk of developing various types of cancer, often at ages younger than typically seen in the general population, ...
SAN DIEGO, July 13, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (CRNX) (Nasdaq: CRNX) today announced new data from its clinical development program evaluating once-daily, oral ...
Acromegaly is a rare disease that causes facial and skeletal bone deformities, as well as heart complications, diabetes and cancer It is diagnosed around 10 years after its onset; its World Day is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback